Clinical Trial Update: Autologous Cytokine Induced Killer Cells (CIK) for Patients With Severe Psoriasis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trials explored autologous cytokine-induced killer (CIK) cells as an adoptive immunotherapy for severe psoriasis. The update references compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Autologous Cytokine-Induced Killer (CIK) Cells Therapy (cytokine-induced killer cells)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Psoriasis, Adoptive Immunotherapy | Phase 1, Phase 2 | Status: COMPLETED